Kaštelan, D., Dušek, T., Kraljević, I., Polašek, O., Giljević, Z., Solak, M. ... Koršić, M. (2009). Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine, 36. (1), 70-74. doi: 10.1007/s12020-009-9186-y
Kaštelan, Darko, et al. "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers." Endocrine, vol. 36, no. 1, 2009, pp. 70-74. https://doi.org/10.1007/s12020-009-9186-y
Kaštelan, Darko, Tina Dušek, Ivana Kraljević, Ozren Polašek, Zlatko Giljević, Mirsala Solak, Silva Zupančić Šalek, Jozo Jelčić, Izet Aganović and Mirko Koršić. "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers." Endocrine 36, no. 1 (2009): 70-74. https://doi.org/10.1007/s12020-009-9186-y
Kaštelan, D., et al. (2009) 'Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers', Endocrine, 36(1), pp. 70-74. doi: 10.1007/s12020-009-9186-y
Kaštelan D, Dušek T, Kraljević I, Polašek O, Giljević Z, Solak M, and sur.. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine [Internet]. 2009 August [cited 2024 October 04];36(1):70-74. doi: 10.1007/s12020-009-9186-y
D. Kaštelan, et al., "Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers", Endocrine, vol. 36, no. 1, pp. 70-74, August 2009. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:887716. [Accessed: 04 October 2024]